Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis
Gespeichert in:
| Veröffentlicht in: | Rheumatology international 2011-03, Vol.31 (3), p.403-404 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 404 |
|---|---|
| container_issue | 3 |
| container_start_page | 403 |
| container_title | Rheumatology international |
| container_volume | 31 |
| creator | Pyrpasopoulou, Athina Douma, Stella Vassiliadis, Themistoklis Chatzimichailidou, Sofia Triantafyllou, Areti Aslanidis, Spyros |
| description | |
| doi_str_mv | 10.1007/s00296-009-1202-2 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00568311v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2270888231</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-974c9ca9367fdcf19685f6ae96d320ce93a660af5c07876533dffebd199821293</originalsourceid><addsrcrecordid>eNp1kcFu3CAQQFGVqNmm_YBeKpRbD25nYI3NMYnSptJKkaJE6g2xGGKiXbMBvE3-vrheNadcQAxv3gwMIZ8RviFA8z0BMCkqAFkhA1axd2SBS95UKOD3EVkANqxqy3JCPqT0COUsBLwnJyhbDkvOFyTcWm2y3-vsw0CDo6aPYfCG9nZXYtknekH3Po6J-sFZ8w9zYbMJf_zwQKPP47Pf6jXV3dYPPuWoD0iksbfjVufgO6pj7uNk-0iOnd4k--mwn5L7H1d3l9fV6ubnr8vzVWVq5LmSzdJIoyUXjeuMQyna2gltpeg4A2Ml1-Ul2tUGmrYRNeedc3bdoZQtQyb5Kfk6e3u9UbtYWowvKmivrs9XaooB1KLliHss7NnM7mJ4Gm3K6jGMcSjtqbZmDUPRsgLhDJkYUorW_bciqGkaap5GEUs1TUNNOV8O4nG9td1rxuH7C8BmIJWr4cHG18pvW_8CR16WVQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>852721682</pqid></control><display><type>article</type><title>Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Pyrpasopoulou, Athina ; Douma, Stella ; Vassiliadis, Themistoklis ; Chatzimichailidou, Sofia ; Triantafyllou, Areti ; Aslanidis, Spyros</creator><creatorcontrib>Pyrpasopoulou, Athina ; Douma, Stella ; Vassiliadis, Themistoklis ; Chatzimichailidou, Sofia ; Triantafyllou, Areti ; Aslanidis, Spyros</creatorcontrib><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-009-1202-2</identifier><identifier>PMID: 19830433</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Antibodies, Monoclonal, Murine-Derived - adverse effects ; Antibodies, Monoclonal, Murine-Derived - immunology ; Antibodies, Monoclonal, Murine-Derived - therapeutic use ; Arthritis, Rheumatoid - immunology ; Arthritis, Rheumatoid - therapy ; Case Report ; Female ; Hepatitis B, Chronic - immunology ; Hepatitis B, Chronic - virology ; Humans ; Immunologic Factors - adverse effects ; Immunologic Factors - immunology ; Immunologic Factors - therapeutic use ; Medicine ; Medicine & Public Health ; Middle Aged ; Recurrence ; Rheumatology ; Rituximab</subject><ispartof>Rheumatology international, 2011-03, Vol.31 (3), p.403-404</ispartof><rights>Springer-Verlag 2009</rights><rights>Springer-Verlag 2011</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-974c9ca9367fdcf19685f6ae96d320ce93a660af5c07876533dffebd199821293</citedby><cites>FETCH-LOGICAL-c513t-974c9ca9367fdcf19685f6ae96d320ce93a660af5c07876533dffebd199821293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00296-009-1202-2$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00296-009-1202-2$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>230,314,776,780,881,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19830433$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00568311$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Pyrpasopoulou, Athina</creatorcontrib><creatorcontrib>Douma, Stella</creatorcontrib><creatorcontrib>Vassiliadis, Themistoklis</creatorcontrib><creatorcontrib>Chatzimichailidou, Sofia</creatorcontrib><creatorcontrib>Triantafyllou, Areti</creatorcontrib><creatorcontrib>Aslanidis, Spyros</creatorcontrib><title>Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><addtitle>Rheumatol Int</addtitle><subject>Antibodies, Monoclonal, Murine-Derived - adverse effects</subject><subject>Antibodies, Monoclonal, Murine-Derived - immunology</subject><subject>Antibodies, Monoclonal, Murine-Derived - therapeutic use</subject><subject>Arthritis, Rheumatoid - immunology</subject><subject>Arthritis, Rheumatoid - therapy</subject><subject>Case Report</subject><subject>Female</subject><subject>Hepatitis B, Chronic - immunology</subject><subject>Hepatitis B, Chronic - virology</subject><subject>Humans</subject><subject>Immunologic Factors - adverse effects</subject><subject>Immunologic Factors - immunology</subject><subject>Immunologic Factors - therapeutic use</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Recurrence</subject><subject>Rheumatology</subject><subject>Rituximab</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kcFu3CAQQFGVqNmm_YBeKpRbD25nYI3NMYnSptJKkaJE6g2xGGKiXbMBvE3-vrheNadcQAxv3gwMIZ8RviFA8z0BMCkqAFkhA1axd2SBS95UKOD3EVkANqxqy3JCPqT0COUsBLwnJyhbDkvOFyTcWm2y3-vsw0CDo6aPYfCG9nZXYtknekH3Po6J-sFZ8w9zYbMJf_zwQKPP47Pf6jXV3dYPPuWoD0iksbfjVufgO6pj7uNk-0iOnd4k--mwn5L7H1d3l9fV6ubnr8vzVWVq5LmSzdJIoyUXjeuMQyna2gltpeg4A2Ml1-Ul2tUGmrYRNeedc3bdoZQtQyb5Kfk6e3u9UbtYWowvKmivrs9XaooB1KLliHss7NnM7mJ4Gm3K6jGMcSjtqbZmDUPRsgLhDJkYUorW_bciqGkaap5GEUs1TUNNOV8O4nG9td1rxuH7C8BmIJWr4cHG18pvW_8CR16WVQ</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>Pyrpasopoulou, Athina</creator><creator>Douma, Stella</creator><creator>Vassiliadis, Themistoklis</creator><creator>Chatzimichailidou, Sofia</creator><creator>Triantafyllou, Areti</creator><creator>Aslanidis, Spyros</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><general>Springer Verlag</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>1XC</scope><scope>VOOES</scope></search><sort><creationdate>20110301</creationdate><title>Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis</title><author>Pyrpasopoulou, Athina ; Douma, Stella ; Vassiliadis, Themistoklis ; Chatzimichailidou, Sofia ; Triantafyllou, Areti ; Aslanidis, Spyros</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-974c9ca9367fdcf19685f6ae96d320ce93a660af5c07876533dffebd199821293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibodies, Monoclonal, Murine-Derived - adverse effects</topic><topic>Antibodies, Monoclonal, Murine-Derived - immunology</topic><topic>Antibodies, Monoclonal, Murine-Derived - therapeutic use</topic><topic>Arthritis, Rheumatoid - immunology</topic><topic>Arthritis, Rheumatoid - therapy</topic><topic>Case Report</topic><topic>Female</topic><topic>Hepatitis B, Chronic - immunology</topic><topic>Hepatitis B, Chronic - virology</topic><topic>Humans</topic><topic>Immunologic Factors - adverse effects</topic><topic>Immunologic Factors - immunology</topic><topic>Immunologic Factors - therapeutic use</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Recurrence</topic><topic>Rheumatology</topic><topic>Rituximab</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pyrpasopoulou, Athina</creatorcontrib><creatorcontrib>Douma, Stella</creatorcontrib><creatorcontrib>Vassiliadis, Themistoklis</creatorcontrib><creatorcontrib>Chatzimichailidou, Sofia</creatorcontrib><creatorcontrib>Triantafyllou, Areti</creatorcontrib><creatorcontrib>Aslanidis, Spyros</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pyrpasopoulou, Athina</au><au>Douma, Stella</au><au>Vassiliadis, Themistoklis</au><au>Chatzimichailidou, Sofia</au><au>Triantafyllou, Areti</au><au>Aslanidis, Spyros</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis</atitle><jtitle>Rheumatology international</jtitle><stitle>Rheumatol Int</stitle><addtitle>Rheumatol Int</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>31</volume><issue>3</issue><spage>403</spage><epage>404</epage><pages>403-404</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>19830433</pmid><doi>10.1007/s00296-009-1202-2</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0172-8172 |
| ispartof | Rheumatology international, 2011-03, Vol.31 (3), p.403-404 |
| issn | 0172-8172 1437-160X |
| language | eng |
| recordid | cdi_hal_primary_oai_HAL_hal_00568311v1 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Antibodies, Monoclonal, Murine-Derived - adverse effects Antibodies, Monoclonal, Murine-Derived - immunology Antibodies, Monoclonal, Murine-Derived - therapeutic use Arthritis, Rheumatoid - immunology Arthritis, Rheumatoid - therapy Case Report Female Hepatitis B, Chronic - immunology Hepatitis B, Chronic - virology Humans Immunologic Factors - adverse effects Immunologic Factors - immunology Immunologic Factors - therapeutic use Medicine Medicine & Public Health Middle Aged Recurrence Rheumatology Rituximab |
| title | Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A16%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reactivation%20of%20chronic%20hepatitis%20B%20virus%20infection%20following%20rituximab%20administration%20for%20rheumatoid%20arthritis&rft.jtitle=Rheumatology%20international&rft.au=Pyrpasopoulou,%20Athina&rft.date=2011-03-01&rft.volume=31&rft.issue=3&rft.spage=403&rft.epage=404&rft.pages=403-404&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-009-1202-2&rft_dat=%3Cproquest_hal_p%3E2270888231%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=852721682&rft_id=info:pmid/19830433&rfr_iscdi=true |